Translational PsychiatryNeurosciencePeer-reviewed journal article
Novel polygenic risk score as a translational tool linking depression-related changes in the corticolimbic transcriptome with neural face processing and anhedonic symptoms
Klára MarečkováiD, Colin S. HawcoiD, Fernanda C. Dos SantosiD, Arin Bakht, Navona CalarcoiD, Amy E. MilesiD, Aristotle N. VoineskosiD, Etienne L. SibilleiD, Ahmad R. HaririiD, Yuliya S. NikolovaiD
Abstract
Convergent data from imaging and postmortem brain transcriptome studies implicate corticolimbic circuit (CLC) dysregulation in the pathophysiology of depression. To more directly bridge these lines of work, we generated a novel transcriptome-based polygenic risk score (T-PRS), capturing subtle shifts towards depression-like gene expression patterns in key CLC regions, and mapped this T-PRS onto brain function and related depressive symptoms in a non-clinical sample of 478 young adults (225 men; age 19.79+/-1.24) from the Duke Neurogenetics Study. First, T-PRS was generated based on common functional SNPs shifting CLC gene expression towards a depression-like state. Next, we used multivariate partial least squares regression to map T-PRS onto whole-brain activity patterns during perceptual processing of social stimuli (i.e., human faces). For validation, we conducted a comparative analysis with a PRS summarizing depression risk variants identified by the Psychiatric Genomics Consortium (PGC-PRS). Sex was modeled as moderating factor. We showed that T-PRS was associated with widespread reductions in neural response to neutral faces in women and to emotional faces and shapes in men (multivariate p<0.01). This female-specific reductions in neural response to neutral faces was also associated with PGC-PRS (multivariate p<0.03). Reduced reactivity to neutral faces was further associated with increased self-reported anhedonia. We conclude that women with functional alleles mimicking the postmortem transcriptomic CLC signature of depression have blunted neural activity to social stimuli, which may be expressed as higher anhedonia.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 16
- FWCI
- 0.73
- Field percentile
- top 30%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel polygenic risk score links depression-related cortical transcriptomic changes to brain morphology and symptom severity
Amy E. Miles, Fernanda C. Dos Santos, … Yuliya S. Nikolova·NeuropsychopharmacologyPeer-reviewed·Sep 29, 2021
- Distinct Neurodevelopmental Signatures of Sex-Specific Transcriptome-Based Polygenic Risk Scores for Depression
Sarah S. Rashid, Kevan P. Clifford, … Yuliya S. Nikolova·medRxiv·Jul 31, 2025
- A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank
Xueyi Shen, David M. Howard, … Michael John Owen·Nature CommunicationsPeer-reviewed·May 8, 2020
- Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: meta-analysis of three treatment cohorts.
Joey Ward, Nicholas Graham, … Daniel J. Smıth·PLoS ONEPeer-reviewed·Sep 21, 2018
- Using polygenic and transcriptional risk scores to investigate psychiatric and cognitive symptoms in Parkinson's disease
Lachlan Gilchrist, Oliver Pain, … Petroula Proitsi·medRxiv·Mar 20, 2025
- Viewing Direct-to-Consumer Genetic Test Results for Depression Risk Is Psychologically Well Tolerated: Evidence from a Longitudinal Equivalence Study
Rebecca M. K. Berns, Devika Dhamija, … Noura S. Abul‐Husn·Human Genetics and Genomics AdvancesPeer-reviewed·Dec 8, 2025